Skip directly to search Skip directly to A to Z list Skip directly to site content
CDC Home

Volume 7, Number 6—December 2001

Dispatch

Legionella-Like and Other Amoebal Pathogens as Agents of Community-Acquired Pneumonia

Thomas J. Marrie*Comments to Author , Didier Raoult†, Bernard La Scola†, Richard J. Birtles†, Emidio de Carolis‡, and the Canadian Community-Acquired Pneumonia Study Group
Author affiliations: *Department of Medicine University of Alberta, Edmonton, Alberta, Canada;; †Faculté de Médecine de Marseille, Marseille, France;; ‡Pfizer Canada Inc., Montreal, Quebec, Canada

Main Article

Table 1

Percent seropositivity (antibody titer ³1:50) to various antigens among three study groupsa

Antigen Healthy Nova Scotians (%)
N = 511 Ambulatory Pneumonia (%)
N = 121 CAP requiring Hospitalization (%)
N = 255
LLAP-1 0.19 1.6 0.7
LLAP-2 0 0 0.39
LLAP-3 0.39 1.6 0.7
LLAP-4 0.39 0 4.3
LLAP-6 0.1 0 0.39
LLAP-7 1.36 0 1.56
LLAP-9 0.39 1.6 0.7
LLAP-10 0 0 0.7
LLAP-12 0.97 1.6 0.39
Hall's coccus 0 1.6 2.35
BN 9 0 0 2.35
Afipia felis
0
0.82
0

aAs defined in paper.
CAP = community-acquired pneumonia.

Main Article

1R. Duperval, S. Field, T. Louie, S. Houston, M. Gribble, K. Williams, L. Nicolle, R. Grossman, I. Salit, R. Saginur, D. Gregson, M. Laverdiere, Jean Joly, T. Marrie, and J. Hutchinson.

Top of Page

USA.gov: The U.S. Government's Official Web PortalDepartment of Health and Human Services
Centers for Disease Control and Prevention   1600 Clifton Rd. Atlanta, GA 30333, USA
800-CDC-INFO (800-232-4636) TTY: (888) 232-6348 - Contact CDC–INFO